Literature DB >> 12592037

Vasovasostomy.

I Schroeder-Printzen1, Th Diemer, W Weidner.   

Abstract

Vasovasostomy after sterilisation vasectomy is the most frequently performed microsurgical intervention in refertilizing surgery. Causes for obstruction other than vasectomy such as juvenile hernia repair and other kinds of surgery affecting the seminal cord appear to be rare. The pre-operative diagnostic approach follows the rules of conventional diagnostics in male infertility. The significance of the intra-operative evaluation of aspirates from the duct and its role in surgical decision-making is controversely debated in the literature. Similar controversies are evident concerning the microsurgical technique that is applied. In particular, the advantages of the two-layered technique (gold standard) of the anastomosis versus the single-layered technique are discussed. Other techniques such as laser applications and fibrin glue are not routinely used in humans. Even difficult microsurgical problems in cases with extended obstructions and cases of re-vasovasostomy can nowadays be managed and have significant success rates. Important prognostic factors appear to be the interval of obstruction, sperm granulomas, and length of the testicular end of the duct. High success rates accompanied by a lower profile in cost make the microsurgical approach (refertilization) superior versus the primary use of ART techniques such as ICSI. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12592037     DOI: 10.1159/000068182

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  [Infertility--diagnosis and therapy. An indispensable building block of urologic andrology].

Authors:  W Weidner; K Diedrich; T Diemer; S Kliesch; H Sperling
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 2.  [Therapy for infertile couples].

Authors:  H Sperling; A Eisenhardt; M Becker; H Rübben
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

3.  [New aspects of case law on andrological questions: what does this mean for physicians in private practice?].

Authors:  I Schroeder-Printzen; J Schroeder-Printzen; J Gleissner; W Weidner
Journal:  Urologe A       Date:  2008-12       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.